PRODROMAL SCHIZOPHRENIA
Clinical trials for PRODROMAL SCHIZOPHRENIA explained in plain language.
Never miss a new study
Get alerted when new PRODROMAL SCHIZOPHRENIA trials appear
Sign up with your email to follow new studies for PRODROMAL SCHIZOPHRENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a brain booster stop schizophrenia before it starts?
Disease control Recruiting nowThis study tests whether a drug that boosts NMDA receptors can help people with early signs of schizophrenia. About 48 participants with prodromal symptoms will take the drug for 12 weeks. The goal is to see if it reduces symptom severity and delays progression.
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Brain training may boost social skills in at-risk teens
Disease control Recruiting nowThis study tests a 10-week cognitive training program called SCORES for teens at high risk for psychosis. The program aims to improve processing speed (how fast the brain handles information) through game-like tasks, group coaching, and rewards. Researchers hope better processing…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common antioxidant ease early psychosis symptoms?
Symptom relief Recruiting nowThis study tests whether N-acetylcysteine (NAC), a safe antioxidant supplement, can reduce early psychosis-like symptoms in 90 people at clinical high risk for schizophrenia. Participants take NAC for 8 weeks, and researchers measure changes in symptoms and brain activity. The go…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC